Publications by authors named "R Woessner"

Claim this Profile
E
Evaluation of STK17B as a cancer immunotherapy target utilizing highly potent and selective small molecule inhibitors.
Felix Scheuplein, Florian Renner, John E Campbell, Robert Campbell, Chris De Savi, Richard Woessner

Front Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of osimertinib-resistant non-small-cell lung cancer.
Sun Min Lim, Stefanie S Schalm, Eun Ji Lee, Sewon Park, Chiara Conti, Rich Woessner

Ther Adv Med Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Assessment of Pharmacokinetics, Pharmacodynamics, and Tolerability of Ligelizumab in Healthy Volunteers and Patients with Chronic Spontaneous Urticaria to Optimize Its Subcutaneous Delivery System.
Yan Ji, Claudio Calonder, Tiina Kirsilä, Alis Burciu, Matjaz Tisu, Ralph Woessner

Pharmaceutics· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Study to Evaluate Relative Bioavailability, Food Effect, and Pharmacodynamics of Tropifexor, a Farnesoid X Receptor Agonist, in Healthy Participants.
Rowan Stringer, Jin Chen, Bharti Shah, Jessie Gu, Yiming Zhang, Ralph Woessner

Clin Pharmacol Drug Dev· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe olanzapine-induced liver function test elevation.
Ericka Crouse, Rose Woessner

Ment Health Clin· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis